We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$35.5B
AUM Growth
+$2.63B
Cap. Flow
-$358M
Cap. Flow %
-1.01%
Top 10 Hldgs %
19.61%
Holding
1,339
New
136
Increased
426
Reduced
527
Closed
93

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$78.4M
2
STLA icon
Stellantis
STLA
+$64.2M
3
AAPL icon
Apple
AAPL
+$56.5M
4
CINF icon
Cincinnati Financial
CINF
+$36.6M
5
MA icon
Mastercard
MA
+$33.9M

Top Sells

Rank Stock Value
1
PFPT
Proofpoint, Inc.
PFPT
+$121M
2
EPAM icon
EPAM Systems
EPAM
+$65.3M
3
NVDA icon
NVIDIA
NVDA
+$47.2M
4
VLO icon
Valero Energy
VLO
+$46.8M
5
AMAT icon
Applied Materials
AMAT
+$46.6M

Sector Composition

Rank Sector Weight
1 Technology 30.03%
2 Healthcare 16.84%
3 Consumer Discretionary 12.32%
4 Financials 10.53%
5 Industrials 8.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UPBD icon
626
Upbound Group
UPBD
$1.17B
$6.15M 0.02%
115,900
-13,000
-10% -$755K
RH icon
627
RH
RH
$3.15B
$6.11M 0.02%
+9,000
New +$5.84M
QGEN icon
628
Qiagen
QGEN
$8.55B
$6.07M 0.02%
118,265
-12,846
-10% -$663K
ROST icon
629
Ross Stores
ROST
$81B
$6.04M 0.02%
48,663
-691
-1% -$86.2K
ACH
630
Accendra Health
ACH
$256M
$6M 0.02%
141,700
-41,300
-23% -$1.61M
BCYC
631
Bicycle Therapeutics
BCYC
$280M
$6M 0.02%
197,510
-289
-0.1% -$8.73K
NTLA icon
632
Intellia Therapeutics
NTLA
$1.55B
$5.99M 0.02%
+36,986
New +$2.88M
HRL icon
633
Hormel Foods
HRL
$14B
$5.97M 0.02%
124,998
+87,086
+230% +$4.15M
FTI icon
634
TechnipFMC
FTI
$27.5B
$5.95M 0.02%
657,680
+311,189
+90% +$2.63M
MED icon
635
Medifast
MED
$110M
$5.94M 0.02%
21,000
-2,900
-12% -$786K
AOS icon
636
A.O. Smith
AOS
$8.24B
$5.94M 0.02%
82,400
-99,700
-55% -$6.88M
WB icon
637
Weibo
WB
$1.99B
$5.91M 0.02%
112,300
+2,300
+2% +$114K
TRV icon
638
Travelers Companies
TRV
$78.4B
$5.87M 0.02%
39,235
-15,308
-28% -$2.38M
ALXO icon
639
ALX Oncology
ALXO
$262M
$5.82M 0.02%
106,422
+11,724
+12% +$702K
NGM
640
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$5.77M 0.02%
+292,441
New +$6.84M
SYKE
641
DELISTED
SYKES Enterprises Inc
SYKE
$5.75M 0.02%
107,000
-32,900
-24% -$1.46M
NTAP icon
642
NetApp
NTAP
$34.1B
$5.74M 0.02%
70,111
+48,239
+221% +$3.77M
VIPS icon
643
Vipshop
VIPS
$7.3B
$5.73M 0.02%
285,522
-358,000
-56% -$9M
FCN icon
644
FTI Consulting
FCN
$4.95B
$5.66M 0.02%
41,400
+24,000
+138% +$3.38M
INGR icon
645
Ingredion
INGR
$6.33B
$5.66M 0.02%
62,491
-11,400
-15% -$1.06M
IIPR icon
646
Innovative Industrial Properties
IIPR
$1.76B
$5.65M 0.02%
29,600
+10,900
+58% +$2M
EWBC icon
647
East-West Bancorp
EWBC
$17.9B
$5.61M 0.02%
78,300
-19,100
-20% -$1.42M
MKSI icon
648
MKS Inc
MKSI
$19.8B
$5.61M 0.02%
31,500
-22,900
-42% -$4.16M
EAT icon
649
Brinker International
EAT
$9B
$5.58M 0.02%
90,300
+87,400
+3,014% +$5.53M
IRWD icon
650
Ironwood Pharmaceuticals
IRWD
$614M
$5.57M 0.02%
+432,900
New +$4.96M
24 25
26
27 28

Similar funds

PHAM
Palisades Hudson Asset Management Fort Lauderdale, Florida $257M AUM 21.62% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
EBWM
Eagle Bluffs Wealth Management Columbia, Missouri $257M AUM 30.19% 1-Year Est. Return
GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
CIA
Corigliano Investment Advisers Raleigh, North Carolina $256M AUM 54.89% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
ACM
ADW Capital Management Miami Beach, Florida $257M AUM 11.22% 1-Year Est. Return
CCA
Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return

Axa's Q2 2021 Portfolio in Review

As of Q2 2021, Axa held 1,339 positions worth $35.5B, up 8% from $32.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Axa's Q2 2021 filing shows 136 new, 426 increased, 527 reduced and 93 closed positions. Its largest new stake was Sprinklr: 1,100,000 shares worth $22.6M. The largest sale was Proofpoint, Inc., an estimated $121M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q2 2021 buy was Sprinklr: 1,100,000 shares worth $22.6M.
  • Axa added most to Berkshire Hathaway Class B in Q2 2021, an estimated $78.4M increase.
  • Axa's biggest Q2 2021 reduction was Proofpoint, Inc., cutting an estimated $121M.
  • Axa fully exited Arthur J. Gallagher & Co in Q2 2021, selling an estimated $33.5M.
  • Axa's ten largest holdings make up 20% of its $35.5B portfolio in Q2 2021.
  • Axa opened 136 new positions and closed 93 in Q2 2021.
  • Axa's portfolio value rose 8% quarter-over-quarter to $35.5B.

Based on Axa's 13F filing for Q2 2021, filed 13 Aug 2021.